BCL-2 inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BCL-2 inhibitor, covering 2025-09-08 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: BCL2i CLAG-M in R/R Acute Myeloid Leukemia [Phase 2]